Showing results (171-180 of 314) with videos related to

Sort By:
Pageof 32
BJUI Compass|January 5, 2024
Co-designing an online treatment decision aid for men with low-risk prostate cancer: NavigatePenelope Schofield, Amelia Hyatt, Alan White, et al.
European Urology|January 18, 2015
Robot-assisted radical cystectomy and urinary diversion: technical recommendations from the Pasadena Consensus PanelKevin G Chan, Khurshid Guru, Peter Wiklund, et al.
Nature Reviews. Urology|December 6, 2022
Using PSMA imaging for prognostication in localized and advanced prostate cancerMatthew J Roberts, Tobias Maurer, Marlon Perera, et al.
European Urology|December 20, 2020
Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA TrialRafael E de Feria Cardet, Michael S Hofman, Tatiana Segard, et al.
European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.
European Urology|December 29, 2009
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complicationsDeclan G Murphy, Anders Bjartell, Vincenzo Ficarra, et al.
BJU International|April 14, 2026
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancerAbdullah Al-Khanaty, David Chen, Jonathan Walbaum, et al.
The Medical Journal of Australia|October 2, 2022
Modern paradigms for prostate cancer detection and managementIsabella Sc Williams, Aoife McVey, Sachin Perera, et al.
Physics and Imaging in Radiation Oncology|March 14, 2022
A statistical, voxelised model of prostate cancer for biologically optimised radiotherapyRobert N Finnegan, Hayley M Reynolds, Martin A Ebert, et al.
The Journal of Urology|October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
Pageof 32